Aryl nucleoside H-phosphonates. Part 15: Synthesis, properties and, anti-HIV activity of aryl nucleoside 5'-alpha-hydroxyphosphonates. 2006

Agnieszka Szymańska, and Marzena Szymczak, and Jerzy Boryski, and Jacek Stawiński, and Adam Kraszewski, and Gabriella Collu, and Giseppina Sanna, and Gabriele Giliberti, and Roberta Loddo, and Paolo La Colla
Institute of Bioorganic Chemistry, Polish Academy of Sciences, Noskowskiego 12/14, 61-704 Poznań, Poland.

Aryl nucleoside 5'-H-phosphonates 4 bearing AZT or 2',3'-dideoxyuridine moieties were subjected to reaction with various aromatic aldehydes to produce nucleoside 5'-alpha-hydroxyphosphonate derivatives 2 as potential anti-HIV agents. Stability of the title compounds in cell culture media was investigated and three distinct decomposition pathways were identified. The anti-HIV activity of hydroxyphosphonates 2 correlates well with the type and extent of their chemical or enzymatic degradation in culture medium (RPMI 1640 containing 10% FBS), suggesting that aryl nucleoside 5'-hydroxyphosphonates 2 act as depot forms of the parent antiviral nucleosides.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D006678 HIV Human immunodeficiency virus. A non-taxonomic and historical term referring to any of two species, specifically HIV-1 and/or HIV-2. Prior to 1986, this was called human T-lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV). From 1986-1990, it was an official species called HIV. Since 1991, HIV was no longer considered an official species name; the two species were designated HIV-1 and HIV-2. AIDS Virus,HTLV-III,Human Immunodeficiency Viruses,Human T-Cell Lymphotropic Virus Type III,Human T-Lymphotropic Virus Type III,LAV-HTLV-III,Lymphadenopathy-Associated Virus,Acquired Immune Deficiency Syndrome Virus,Acquired Immunodeficiency Syndrome Virus,Human Immunodeficiency Virus,Human T Cell Lymphotropic Virus Type III,Human T Lymphotropic Virus Type III,Human T-Cell Leukemia Virus Type III,Immunodeficiency Virus, Human,Immunodeficiency Viruses, Human,Virus, Human Immunodeficiency,Viruses, Human Immunodeficiency,AIDS Viruses,Human T Cell Leukemia Virus Type III,Lymphadenopathy Associated Virus,Lymphadenopathy-Associated Viruses,Virus, AIDS,Virus, Lymphadenopathy-Associated,Viruses, AIDS,Viruses, Lymphadenopathy-Associated
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006880 Hydroxy Acids Organic compounds containing both the hydroxyl and carboxyl radicals. Hydroxy Acid,Acid, Hydroxy,Acids, Hydroxy
D014779 Virus Replication The process of intracellular viral multiplication, consisting of the synthesis of PROTEINS; NUCLEIC ACIDS; and sometimes LIPIDS, and their assembly into a new infectious particle. Viral Replication,Replication, Viral,Replication, Virus,Replications, Viral,Replications, Virus,Viral Replications,Virus Replications
D015215 Zidovudine A dideoxynucleoside compound in which the 3'-hydroxy group on the sugar moiety has been replaced by an azido group. This modification prevents the formation of phosphodiester linkages which are needed for the completion of nucleic acid chains. The compound is a potent inhibitor of HIV replication, acting as a chain-terminator of viral DNA during reverse transcription. It improves immunologic function, partially reverses the HIV-induced neurological dysfunction, and improves certain other clinical abnormalities associated with AIDS. Its principal toxic effect is dose-dependent suppression of bone marrow, resulting in anemia and leukopenia. AZT (Antiviral),Azidothymidine,3'-Azido-2',3'-Dideoxythymidine,3'-Azido-3'-deoxythymidine,AZT Antiviral,AZT, Antiviral,BW A509U,BWA-509U,Retrovir,3' Azido 2',3' Dideoxythymidine,3' Azido 3' deoxythymidine,Antiviral AZT,BWA 509U,BWA509U
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D019380 Anti-HIV Agents Agents used to treat AIDS and/or stop the spread of the HIV infection. These do not include drugs used to treat symptoms or opportunistic infections associated with AIDS. AIDS Drug,AIDS Drugs,Anti-AIDS Agents,Anti-AIDS Drug,Anti-HIV Agent,Anti-HIV Drug,Anti-AIDS Drugs,Anti-HIV Drugs,Agent, Anti-HIV,Agents, Anti-AIDS,Agents, Anti-HIV,Anti AIDS Agents,Anti AIDS Drug,Anti AIDS Drugs,Anti HIV Agent,Anti HIV Agents,Anti HIV Drug,Anti HIV Drugs,Drug, AIDS,Drug, Anti-AIDS,Drug, Anti-HIV,Drugs, AIDS,Drugs, Anti-AIDS,Drugs, Anti-HIV

Related Publications

Agnieszka Szymańska, and Marzena Szymczak, and Jerzy Boryski, and Jacek Stawiński, and Adam Kraszewski, and Gabriella Collu, and Giseppina Sanna, and Gabriele Giliberti, and Roberta Loddo, and Paolo La Colla
May 2009, Bioorganic & medicinal chemistry,
Agnieszka Szymańska, and Marzena Szymczak, and Jerzy Boryski, and Jacek Stawiński, and Adam Kraszewski, and Gabriella Collu, and Giseppina Sanna, and Gabriele Giliberti, and Roberta Loddo, and Paolo La Colla
October 2011, Journal of medicinal chemistry,
Agnieszka Szymańska, and Marzena Szymczak, and Jerzy Boryski, and Jacek Stawiński, and Adam Kraszewski, and Gabriella Collu, and Giseppina Sanna, and Gabriele Giliberti, and Roberta Loddo, and Paolo La Colla
May 2008, Organic letters,
Agnieszka Szymańska, and Marzena Szymczak, and Jerzy Boryski, and Jacek Stawiński, and Adam Kraszewski, and Gabriella Collu, and Giseppina Sanna, and Gabriele Giliberti, and Roberta Loddo, and Paolo La Colla
December 2007, Bioorganic & medicinal chemistry letters,
Agnieszka Szymańska, and Marzena Szymczak, and Jerzy Boryski, and Jacek Stawiński, and Adam Kraszewski, and Gabriella Collu, and Giseppina Sanna, and Gabriele Giliberti, and Roberta Loddo, and Paolo La Colla
April 2018, European journal of medicinal chemistry,
Agnieszka Szymańska, and Marzena Szymczak, and Jerzy Boryski, and Jacek Stawiński, and Adam Kraszewski, and Gabriella Collu, and Giseppina Sanna, and Gabriele Giliberti, and Roberta Loddo, and Paolo La Colla
January 2001, Acta biochimica Polonica,
Agnieszka Szymańska, and Marzena Szymczak, and Jerzy Boryski, and Jacek Stawiński, and Adam Kraszewski, and Gabriella Collu, and Giseppina Sanna, and Gabriele Giliberti, and Roberta Loddo, and Paolo La Colla
January 2013, Bioorganicheskaia khimiia,
Agnieszka Szymańska, and Marzena Szymczak, and Jerzy Boryski, and Jacek Stawiński, and Adam Kraszewski, and Gabriella Collu, and Giseppina Sanna, and Gabriele Giliberti, and Roberta Loddo, and Paolo La Colla
February 2008, Bioorganic & medicinal chemistry letters,
Agnieszka Szymańska, and Marzena Szymczak, and Jerzy Boryski, and Jacek Stawiński, and Adam Kraszewski, and Gabriella Collu, and Giseppina Sanna, and Gabriele Giliberti, and Roberta Loddo, and Paolo La Colla
April 1996, Journal of medicinal chemistry,
Agnieszka Szymańska, and Marzena Szymczak, and Jerzy Boryski, and Jacek Stawiński, and Adam Kraszewski, and Gabriella Collu, and Giseppina Sanna, and Gabriele Giliberti, and Roberta Loddo, and Paolo La Colla
February 2005, Origins of life and evolution of the biosphere : the journal of the International Society for the Study of the Origin of Life,
Copied contents to your clipboard!